Clinical Trials
22 trialsNCT06657157 2026-02-24
P-EVOLUTION
Comprehensive Cancer Center Munich (CCCM)
Recruiting
NCT05889988 2025-11-20
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
Mayo Clinic
Active not recruiting
NCT07160270 2025-09-08
This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process
Rigshospitalet, Denmark
Recruiting
NCT07055711 2025-07-09
Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
Superior University
Active not recruiting
NCT03098589 2025-03-30
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Completed
NCT04287075 2024-03-26
Rethink Pain
Axogen Corporation
Terminated
NCT02428101 2023-11-28
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
Ain Shams University
Unknown
NCT05622617 2022-11-18
NEUROTOX
Namik Kemal University
Unknown
NCT03027245 2022-07-13
IRENE
Eisai Inc.
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT01775254 2018-12-06
The Inland Northwest Colon Cancer Survivor's Study
Washington State University
Completed
NCT03065478 2018-09-06
STEFANO
Swiss Medical Food AG
Completed
NCT01689610 2018-06-20
NABUCCO
iOMEDICO AG
Completed
NCT01697839 2018-03-05
Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Oncotherapeutics
Completed
NCT02492360 2018-02-28
Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Indiana University
Withdrawn
NCT02549534 2017-10-27
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
Indiana University
Completed
NCT03210753 2017-07-13
Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
National Taiwan University Hospital
Unknown
NCT02606110 2017-07-12
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Withdrawn
NCT01982591 2017-06-15
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Fox Chase Cancer Center
Completed
NCT00956033 2014-12-24
Skin Biopsies in Chemotherapy-Induced Neuropathy
Erasmus Medical Center
Completed